
Takeda Spotlights High-Value, Late-Stage Pipeline Accelerating the Development of Potential Transformative Treatments for Patients in Multiple Therapeutic Areas
Osaka, Japan & Cambridge, Mass., United States: Six Late-Stage Programs with Peak Revenue Potential of $10B – $20B1 Poised
















































